Piramal Healthcare UK Ltd., Piramal Pharma Solutions, Whalton Road, Morpeth, Northumberland, NE61 3YA, UK
Our Morpeth, UK facility is a USFDA and MHRA inspected, fully integrated site which offers Active Pharmaceutical Ingredients (APIs) and oral solid drug product development, clinical supply, commercial manufacturing and packaging services to both innovators and generic pharmaceutical companies.
Our Morpeth facility offers formulation development and commercial manufacturing services for all common oral solid dosage forms, particularly for hormonal drug products
We have four reactor blocks with reactor sizes ranging from 50L to 2500L and a dedicated small-scale API plant for manufacturing discrete prostaglandins
Combined with our packaging equipment services, the Morpeth site has a proven track record of shipping clinical trial material to clients within short timelines
The Morpeth site offers comprehensive manufacturing, packaging, and testing services in one location which ensures efficiency in the drug development process and accelerated timelines
Our Morpeth facility offers formulation development and commercial manufacturing services for all common oral solid dosage forms, particularly for hormonal drug products
We have four reactor blocks with reactor sizes ranging from 50L to 2500L and a dedicated small-scale API plant for manufacturing discrete prostaglandins
Combined with our packaging equipment services, the Morpeth site has a proven track record of shipping clinical trial material to clients within short timelines
The Morpeth site offers comprehensive manufacturing, packaging, and testing services in one location which ensures efficiency in the drug development process and accelerated timelines
We have an extensive range of development and manufacturing equipment from wet granulation, roller compaction, fluid bed processing to film coating and tablet-in-tablet manufacturing. The site can manufacture up to 3 billion tablets annually.
Our facility is equipped with 6 high-speed blister packaging and 3 bottle packaging lines which allow us to handle all clinical and commercial packaging needs.
We specialize in the development of oral contraceptive pills, hormone replacement therapies and a wide range of hormonal APIs. Equipped with a dedicated hormonal manufacturing suite, we have the capacity to package up to 1.3 billion tablets and capsules annually.
The Morpeth site is a reliable provider of generic products for US, EU, Japan and RoW markets. Our experienced team can support your ANDA/CTD development needs and assist with regulatory submissions.
We have expertise in managing the entire product development cycle, from early-phase development to commercialization. Customers can greatly accelerate timelines and speed-to-market by leveraging other services in Piramal’s global integrated network.
This facility has a rich experience of 40+ years in handling hormonal products with OEL as low as 0.04 µg/m3. We have robust development and manufacturing equipment and dedicated containment facilities for hormonal products.
Embracing a culture of quality, we integrate rigorous quality checks throughout our operations, ensuring consistent and exceptional product quality. Our teams are dedicated to upholding the highest quality standards at all stages of the development process.
Site was established by G.D. Searle
Site acquired by Piramal Pharma from Pfizer
